Hartford Financial Management’s AbbVie ABBV Stock Holding History

Hartford Financial Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.1K	Hold	191	–	–	0.01%	200
2026 Q1	$41.5K	Hold	191	–	–	0.01%	203
2025 Q4	$43.6K	Hold	191	–	–	0.01%	198
2025 Q3	$44.2K	Hold	191	–	–	0.01%	196
2025 Q2	$35.5K	Sell	191 -25,000	-99%	-$4.65M	0.01%	211
2025 Q1	$5.28M	Hold	25,191	–	–	1.09%	29
2024 Q4	$4.48M	Buy	25,191 +191	+0.8%	+$35.1K	0.92%	38
2024 Q3	$4.94M	Hold	25,000	–	–	1.01%	34
2024 Q2	$4.29M	Sell	25,000 -100	-0.4%	-$16.6K	0.92%	33
2024 Q1	$4.57M	Hold	25,100	–	–	0.97%	33
2023 Q4	$3.89M	Hold	25,100	–	–	0.88%	35
2023 Q3	$3.74M	Hold	25,100	–	–	0.96%	33
2023 Q2	$3.38M	Hold	25,100	–	–	0.84%	42
2023 Q1	$4M	Hold	25,100	–	–	1.03%	32
2022 Q4	$4.06M	Hold	25,100	–	–	1.07%	29
2022 Q3	$3.37M	Hold	25,100	–	–	0.99%	34
2022 Q2	$3.84M	Hold	25,100	–	–	1.07%	30
2022 Q1	$4.07M	Buy	25,100 +100	+0.4%	+$14.5K	0.98%	36
2021 Q4	$3.38M	Sell	25,000 -97	-0.4%	-$11.5K	0.79%	46
2021 Q3	$2.71M	Buy	25,097 +97	+0.4%	+$11.1K	0.69%	57
2021 Q2	$2.82M	Hold	25,000	–	–	0.7%	57
2021 Q1	$2.71M	Buy	25,000 +5,000	+25%	+$535K	0.67%	58
2020 Q4	$2.14M	Hold	20,000	–	–	0.57%	67
2020 Q3	$1.75M	Hold	20,000	–	–	0.52%	72
2020 Q2	$1.96M	Hold	20,000	–	–	0.63%	57
2020 Q1	$1.52M	Hold	20,000	–	–	0.61%	58
2019 Q4	$1.77M	Hold	20,000	–	–	0.55%	69
2019 Q3	$1.51M	Hold	20,000	–	–	0.51%	69
2019 Q2	$1.45M	Hold	20,000	–	–	0.49%	68
2019 Q1	$1.61M	Hold	20,000	–	–	0.55%	66
2018 Q4	$1.84M	Hold	20,000	–	–	0.7%	50
2018 Q3	$1.89M	Hold	20,000	–	–	0.64%	52
2018 Q2	$1.85M	Buy	20,000 +19,840	+12,400%	+$1.94M	0.66%	50
2018 Q1	$15K	Hold	160	–	–	0.01%	236
2017 Q4	$15K	Hold	160	–	–	0.01%	234
2017 Q3	$14K	Hold	160	–	–	0.01%	264
2017 Q2	$11K	Hold	160	–	–	﹤0.01%	273
2017 Q1	$10K	Hold	160	–	–	0.01%	260
2016 Q4	$10K	Sell	160 -900	-85%	-$54.9K	0.01%	233
2016 Q3	$66K	Buy	1,060 +81	+8%	+$5.24K	0.04%	157
2016 Q2	$60K	Hold	979	–	–	0.04%	149
2016 Q1	$55K	Buy	979 +79	+9%	+$4.4K	0.03%	149
2015 Q4	$53K	Sell	900 -1,100	-55%	-$63.4K	0.03%	153
2015 Q3	$108K	Hold	2,000	–	–	0.07%	131
2015 Q2	$134K	Buy	+2,000	New	+$131K	0.08%	126

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hartford Financial Management's ABBV Position: Q2 2026 in Review

Hartford Financial Management held its AbbVie (ABBV) position steady in Q2 2026 at 191 shares worth $48.1K. The position accounts for 0.01% of the portfolio, ranked #200.

Hartford Financial Management first reported a position in ABBV in Q2 2015 and has held it in 45 quarters since. The position peaked at $5.28M in Q1 2025. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hartford Financial Management held 191 shares of AbbVie worth $48.1K as of Q2 2026.
Hartford Financial Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.01% of Hartford Financial Management's portfolio in Q2 2026, its #200 holding.
Hartford Financial Management first reported a position in AbbVie in Q2 2015 and has held it in 45 quarters since.
Hartford Financial Management's AbbVie position peaked at $5.28M in Q1 2025.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.